That changed in March 2023 when a new medical device called Lenire was introduced to the U.S. market. Researchers found over 91% of tinnitus patients saw an improvement with Lenire, according to a ...

Here’s another reason to indulge in that extra cup of coffee: It might just help protect you from tinnitus.. A new study suggests that making certain changes to your diet could help lower your ...

Tinnitus can cause annoying and disruptive ringing, hissing or buzzing in your ears, even though no external sounds are present. Common factors like sleep, caffeine intake and exercise are ...

Explore the existing research surrounding cannabidiol (CBD) as a potential tinnitus treatment, including benefits, risks and safety concerns. CBD For Tinnitus: Does It Work?

Here’s another reason to indulge in that extra cup of coffee: It might just help protect you from tinnitus. A new study ...

Tinnitus affects about 12% of people, including 25% of seniors 65 and older. Most learn to live with the nuisance, but about 15% of people have tinnitus so severe that it disrupts their sleep, ...

That constant ringing in your ears isn’t just annoying — it could be tinnitus. The condition affects more than 50 million ...

The participants’ tinnitus was perceived as only half as loud on average after phase one. Even during the treatment break, the situation continued to improve. The effect lasted up to 36 weeks.

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, will host a commercial webinar on Tuesday ...

This small device helps patients overcome tinnitus, Philadelphia audiologist says 02:26. A growing number of patients are turning to a new treatment for a condition that causes ringing in the ears.

What causes tinnitus? New research suggests that it may be due to hidden hearing loss, not detected on common hearing tests, and may have similarities to phantom limb pain.

—QOL-B Respiratory Domain Shown to Work Effectively as Patient-Reported Outcome Tool in Patients with MAC Lung Disease; to be Proposed to FDA as Primary Endpoint in ENCORE with No Modifications ...